O cancao à pròtesta o l'é o segondo cancao ciù commun tra i òmmi into mondo, con 1,276 mioin de caxi neuvi segnalæ into 2018, ch'o rappresenta o 7,1% de tutti i caxi de cancao tra i òmmi.
O tascio de mortalitæ pe-o cancao à prostata o l"é ascì erto, con unna stima de 37005 mòrti in gio a-o mondo do 2018.
Tutte e mainee, o tascio de mortalitæ o cangia ben ben da region à region, con l'Africa de ponente ch'a l'à o quinto ciù erto reisego de mortalitæ pe cancao à prostata do mondo, e a Nigeria ch'a l'à a ciù grande popolaçion e economia inte sta region.
In Nigeria, o cancao a-a prostata o l'é o cancao ciù commun e ciù mortale pe-i òmmi, con unna stima de 32,8 caxi e 16,3 mòrti pe 100.000 òmmi.
Sto chì o l'é ciù do doî vòtte o tascio de mortalitæ inte l'America do Nòrd.
A scoverta tardiva da mouttia, e risorse limitæ pe-o screening e a descoverta, e a diminuçion da documentaçion e a segnalaçion di caxi contribuiscian à l'erto tascio de mortalitæ in Nigeria.
Inte i Stati Unii, o cancro a-a prostata o l"é a segonda caxon ciù commun de mòrte pe cancro tra i òmmi, con ciù ò meno 40.000 òmmi che meuan da sta mouttia tutti i anni.
O tascio de mortalitæ pe cancao a-a prostata o l'é anæto à diminuî de mainea lenta da-i primmi anni '90, ma o l'arresta un problema de sanitæ importante.
Pe commun, o cancao a-a prostata o l'é unna mouttia mortale, sorviatutto inte regioin con un accesso limitou a-a cura medica e a-e risorse de screening.
Tutte e mainee, a descoverta e o trattamento precoxi peuan megioâ de mainea significativa i exiti e redue i tasci de mortalitæ.
Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol. 2000, 7 (7): 254-7.
Pishgar F, Ebrahimi H, Saeedi Moghaddam S, Fitzmaurice C, Amini E: Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015. J Urol. 2018, 199 (5): 1224-1232.
Cai Q, Chen Y, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, Hou J, Guo X, Zhou X, Zhang B, Ma F, Zhang W, Lin G, Xin Z, Niu Y, Wang Y: Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl Androl Urol. 2020, 9 (2): 196-209.
Feletto E, Bang A, Cole-Clark D, Chalasani V, Rasiah K, Smith DP: An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol. 2015, 33 (11): 1677-87.
Taksler GB, Keating NL, Cutler DM: Explaining racial differences in prostate cancer mortality. Cancer. 2012, 118 (17): 4280-9.
['Disclaimer: medicâ']
["Sto scito web o l'é fornio solo pe di propòxiti educativi e informativi e o no costituisce un conseggio medico ò serviççi profescionæ."]
["L'informaçion fornia a no dovieiva ëse deuviâ pe diagnosticâ ò curâ un problema de sanitæ ò unna mouttia, e quelli che çercan un conseggio medico personale devan consultâ un mego licençiou."]
['Pe piaxei, ti ti o sæ che a ræ neurale ch\'a genera de respòste a-e domande a l"é inprecisa sorviatutto quande se tratta de contegnui numerichi, comme o numero de persoñe che gh\'é stæto diagnosticou unna mouttia particolâ.']
["çercâ delongo o conseggio do teu mego ò de un atro fornitô de sanitæ qualificou in sciâ condiçion medica. no trascurâ mai o conseggio de un mego profescionista ò ritardâ a çercâlo apreuvo à quarcösa che ti t'æ lezuo in sce sto scito web."]
['Disclaimer: copyright']
["O Digital Millennium Copyright Act do 1998, 17 U.S.C. § 512 (o DMCA) o fornisce un ricorso pe-i propietäi de copyright che creddan che o materiale ch'o l'appare in sce Internet o l'infrange i seu driti segondo a leze di copyright di Stati Unii. "]
["Se ti ti creddi de bonn-a fede che un qualunque contegnûo ò materiale misso a dispoxiçion in connescion co-o nòstro scito web ò serviççi o l'infrange i teu driti d'autô, ti (ò o teu agente) ti peu mandâne 'na notifica con domandâ che o contegnûo ò o materiale o segge levòu ò che l'acesso o segge bloccou."]
['E comunicaçioin devan vegnî mandæ pe iscritto pe email (veddi a seçion "Contact" pe l\'indirissô email).']
["O DMCA o l'exige che a teu notifica de presunta violaçion di driti d'autô a contégne e informaçioìn chi sótta: (1) descriçion de l'euvia protetta da driti d'autô ch'a l'é l'oggetto da presunta violaçion; (2) descriçion do contegnûo che se presumibilmente o l'é a violaçion e informaçioìn suffiçienti pe permette a niatri de localizzâlo; (3) informaçioìn de contatto pe ti, compreiso o teu indirìsso, o teu nómme de telefonin e o teu indirìsso email; (4) 'na teu affermaçion che ti ti credi de bonn-a fêde che o contegnûo into mòddo reclamòu o no segge autorizòu da-o propietâio di driti d'autô, ò da-o seu agente, ò da l'açion de quæ se segge leze; "]
["(5) unna declaraçion da parte teu, firmâ sotta pena de perjurio, che e informaçioin inta notifica son accuræ e che ti gh'æ l'autoritæ de fâ respettâ i driti d'autô che se sostegne che seggian stæti violati;"]
["e (6) unna firma fixica ò elettrònica do propietäio do drito d'autô ò de unna persoña autorisâ à agî a-o seu nomme."]
["Se no ti inserisci tutte e informaçioin chì de d'ato, o peu comportâ un retardo into trattamento da teu lamentela."]
['Contatto']
["Pe piaxei manda 'na mail con ògni domanda/suggerimento."]
How deadly is prostate cancer?
Prostate cancer is the second most common cancer in men worldwide, with an estimated 1.276 million new cases reported in 2018, representing 7.1% of all cancer cases in men.
The mortality rate for prostate cancer is also high, with an estimated 37,005 deaths worldwide in 2018.
However, the mortality rate varies greatly by region, with Western Africa having the fifth-highest risk for prostate cancer mortality in the world, and Nigeria having the largest population and economy in this region.
In Nigeria, prostate cancer is both the most common and most deadly cancer for men, with an estimated 32.8 cases and 16.3 deaths per 100,000 men.
This is more than double the death rate in North America.
Late detection of the disease, limited resources for screening and detection, and decreased documentation and reporting of cases contribute to the high mortality rate in Nigeria.
In the United States, prostate cancer is the second most common cause of cancer death in men, with approximately 40,0000 men dying from the disease each year.
The prostate cancer death rate has been slowly decreasing since the early 1990s, but it remains a significant health concern.
Overall, prostate cancer is a deadly disease, particularly in regions with limited access to medical care and screening resources.
However, early detection and treatment can significantly improve outcomes and reduce mortality rates.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['In sciâ']
['BioMedLib o deuvia di computer automatizzæ (algoritmi de machine learning) pe generâ de cobbie de domande e respòste.']
['Comensemmo con 35 mioin de pubricaçioin biomediche de PubMed/Medline.']
